Biomolecular Diagnostic

What Biomolecular Diagnostic does

Biomolecular Diagnostic srl is an Italian molecular diagnostics laboratory founded in 2018 and headquartered in Florence, Italy, operating from Viale Belfiore 34 with a registered capital of €100,000. The company specializes in genomics and metagenomics-based diagnostic testing for clinical professionals — primarily dentists, periodontists, gynecologists, and obstetricians — and additionally operates as an accredited laboratory under the Tuscan regional health service (Servizio Sanitario Toscana, accreditation n. 5526 dated 20 April 2020), enabling reimbursement for blood analysis under the public health system. It maintains a clean safety record with zero adverse events or compensation claims across 2020–2023 and carries a Generali professional liability policy.

The company's product portfolio is built on three core technology platforms: RealTime-PCR with TaqMan probes for high-specificity pathogen detection, ELISA-based enzymatic assays (notably aMMP-8 for periodontal disease), and massively parallel DNA sequencing (MPS) for non-invasive prenatal testing. Flagship offerings include the Bacterial Periodontal Assessment (BPA) test in three panel tiers (5, 7, and 10 bacteria), the GPS genetic periodontal screening panel covering seven inflammatory-mediator polymorphisms, the Vaginal Path Test (VPT) vaginal microbiome panel with individual quantification of four Lactobacilli species alongside 30+ pathogens, a 13-genotype HPV test, and the Vera/Verifi NIPT validated for singleton and twin pregnancies using a proprietary SAFeR algorithm that avoids fetal fraction estimation. Supporting services include the Biomolecular Academy (Ministry-of-Health-accredited clinician training), a B2B molecular biology service for external laboratories, salivary testing, and home blood draws.

Biomolecular Diagnostic generates revenue primarily through per-test laboratory service fees billed to clinicians and patients, with a portion reimbursed through the Tuscan ASL convention for blood analysis. Distribution is regional: kits are shipped via courier within two days of order, results are delivered to clinicians by email and through the jlab.biomoleculardiagnostic.com portal, and a home blood-draw service covers the Florence metropolitan area. The go-to-market is sales-led and education-driven, combining direct enterprise engagement with continuous medical education through Biomolecular Academy, a long-running scientific blog, and a partnership with the IMI Excellence Dental Network. There is no disclosed geographic expansion beyond Italy and no disclosed external funding.

Name

Biomolecular Diagnostic

Legal name

Biomolecular Diagnostic srl

Website

https://biomoleculardiagnostic.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Biomolecular Diagnostic is a Florence-based molecular diagnostics laboratory providing genomics and metagenomics testing to dentists, gynecologists, and obstetricians, plus ASL-conventioned blood analysis for the Tuscan public health system.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

• Molecular diagnostics services
• Genomic laboratory testing
• Periodontal disease diagnostics
• Non-invasive prenatal testing
• Vaginal microbiome testing

Headquarters

HQ city

Firenze

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Laboratory Diagnostic Testing Services: Biomolecular Diagnostic generates revenue primarily through providing laboratory diagnostic tests to clinical professionals. Tests are ordered by physicians/dentists who then forward sample collection kits to patients; samples are returned to the laboratory for analysis and results are delivered to the clinician. Revenue accrues per test performed. The company operates as a conventioned ASL laboratory, meaning certain blood tests are covered under the public health system.
2. Molecular Biology Service for External Laboratories: The company offers a 'Service Biologia Molecolare' (molecular biology service) providing PCR and other molecular biology analyses to external laboratories and healthcare facilities on a service contract basis.
3. Enzyme and Microbiological Test Kits: Home collection kits (e.g., periodontal test strips for crevicular fluid, vaginal swabs) are shipped to clinicians/patients via courier within 2 days of online order. Revenue is generated per kit distributed.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Biomolecular Diagnostic is a private Italian diagnostic laboratory that performs molecular diagnostic testing services using genomics and metagenomics techniques. The company offers RealTime-PCR-based microbiological tests, ELISA-based enzymatic tests, and massively parallel sequencing (NIPT) for clinical professionals in dentistry, gynecology, obstetrics, and general practice, as well as blood analysis under Italy's public health system (ASL Toscana convention).

Product overview

Biomolecular Diagnostic is a research and diagnostic laboratory specializing in genomics and metagenomics for precision medicine. The company operates a modular diagnostic portfolio centered on molecular biology testing, with core offerings in periodontal disease testing (BPA test variants, GPS genetic screening, MMP-8 enzyme testing), gynecological diagnostics (VPT vaginal microbiome panel, HPV testing, Vera Prenatal NIPT), and general laboratory services. The product ecosystem includes three BPA microbiological test tiers (BASIC/LITE/PLUS) differentiated by bacterial panel size, the VPT platform with multiple panel configurations (Full Panel, Vaginosis, Candida, STD, Fertility), and specialized services such as the Biomolecular Academy training platform and Molecular Biology Service for B2B partners. Supporting services include home blood draws and ASL-affiliated blood testing, positioning the company as a comprehensive diagnostic partner for clinical professionals in prevention, diagnosis, treatment, and follow-up phases.

Differentiator

Problem solved

Functional benefit

Brands

• Biomolecular Academy: An academy of high training and medical-scientific research, promoting constant dialogue between medical and scientific professions to enhance clinical and research work in multidisciplinary integration.

Products and services

• Vaginal Path Test (VPT)

Quantifiable outcome

• Test results in 3 days vs. 20+ days for traditional culture-based vaginal infection testing
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• IMI — Excellence Dental Network (EDN)coreStrategic or Co-development PartnerBiomolecular Academy is partnered with IMI (Excellence Dental Network), a professional dental network organization. The partnership supports the academy's educational mission and provides a distribution channel for Biomolecular Diagnostic's tests through the network of affiliated dental practices.
• Specialized Dental Centers (for GPS Test Development)coreStrategic or Co-development PartnerBiomolecular Diagnostic collaborated with specialized dental centers to develop the GPS (Genetic Periodontal Screening) test, which extends beyond the pre-2009 commercial test by analyzing polymorphisms in 7 inflammatory mediators (IL-1α, IL-1β, IL-1RN, IL-10, IL-6, COX-2, VDR) rather than just IL-1 loci alone.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Geneticlab: Italian molecular diagnostics laboratory offering genetic, microbiological, and NIPT testing services with similar B2B clinician-driven model. Closest direct peer in geography, customer base, and molecular test menu.
• Natera: Global NIPT and molecular diagnostics specialist offering Panorama NIPT and related reproductive health tests. Directly comparable in NIPT technology and clinical positioning, though at much larger scale.
• Eurofins Genoma Group: Italian molecular diagnostics lab within the Eurofins network offering NIPT, prenatal screening, genetic testing, and microbiology panels. Comparable in test menu and clinician channel, with larger commercial scale.
• BMR Genomics: Italian genomics and molecular diagnostics service provider serving clinicians and researchers with PCR, sequencing, and cytogenetic testing. Overlapping in technology stack and clinical customer base.

Broad incumbents

• QIAGEN: Global molecular diagnostics and sample technologies company offering PCR-based test kits, instruments, and bioinformatics used in similar qPCR workflows. Enabler/incumbent across the molecular diagnostics value chain.
• BGI Genomics: Global genomics and NIPT provider with broad molecular diagnostics portfolio including non-invasive prenatal testing comparable to Biomolecular Diagnostic's Vera Prenatal offering.
• Cerba HealthCare Italia: European diagnostics group with Italian operations providing specialty and routine clinical laboratory services including molecular diagnostics. Competes broadly in the same clinical specialist channel.
• Sonic Healthcare: Global medical diagnostics provider with extensive European footprint offering clinical laboratory and molecular diagnostics services. Broad incumbent operating in similar clinician-driven channels.
• Synlab Italia: Largest Italian clinical diagnostics network offering broad routine and specialty lab testing including molecular diagnostics. Broader portfolio and geographic footprint, with overlapping capabilities in NIPT and infectious disease molecular testing.

Others

• Illumina: Provider of NGS sequencing platforms underpinning Biomolecular Diagnostic's NIPT and broader sequencing workflows. Adjacent technology enabler rather than direct clinical competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/BDfirenze

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomolecular Diagnostic